News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,227 Results
Type
Article (1922)
Company Profile (3)
Press Release (67302)
Section
Business (21463)
Career Advice (9)
Deals (4552)
Drug Development (8162)
FDA (1804)
Job Trends (802)
News (37016)
Policy (3560)
Tag
Academia (93)
Alliances (8116)
Alzheimer's disease (118)
Antibody-drug conjugate (ADC) (8)
Approvals (1816)
Artificial intelligence (9)
Bankruptcy (8)
Best Places to Work (584)
Biosimilars (13)
Breast cancer (13)
Cancer (150)
Career advice (9)
Cell therapy (14)
Clinical research (6930)
Collaboration (60)
COVID-19 (184)
C-suite (7)
Data (135)
Diabetes (11)
Diagnostics (589)
Drug discovery (12)
Duchenne muscular dystrophy (7)
Earnings (7493)
Events (6878)
Executive appointments (37)
FDA (1893)
Funding (41)
Gene therapy (14)
GLP-1 (41)
Government (233)
Healthcare (1073)
Infectious disease (188)
Inflammatory bowel disease (14)
Intellectual property (7)
IPO (1614)
Job creations (240)
Job search strategy (9)
Layoffs (6)
Legal (945)
Liver cancer (15)
Lung cancer (25)
Lymphoma (8)
Manufacturing (23)
Medical device (1111)
Medtech (1112)
Mergers & acquisitions (3002)
Metabolic disorders (30)
Neuroscience (149)
NextGen: Class of 2025 (221)
Non-profit (61)
Northern California (109)
Obesity (12)
Ovarian cancer (7)
Parkinson's disease (12)
Patents (11)
People (4930)
Phase I (1886)
Phase II (2895)
Phase III (2636)
Pipeline (58)
Postmarket research (241)
Preclinical (651)
Radiopharmaceuticals (22)
Rare diseases (20)
Real estate (598)
Regulatory (2539)
Reports (6)
Research institute (93)
Schizophrenia (6)
Series A (11)
Southern California (100)
Startups (421)
Supply chain (6)
United States (920)
Vaccines (19)
Date
Today (11)
Last 7 days (38)
Last 30 days (154)
Last 365 days (3202)
2025 (135)
2024 (3254)
2023 (3815)
2022 (7015)
2021 (6374)
2020 (5874)
2019 (3863)
2018 (3010)
2017 (3561)
2016 (3171)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Asia (21208)
Australia (2420)
California (241)
Canada (179)
China (118)
Connecticut (11)
Europe (12311)
Florida (14)
Illinois (15)
India (6)
Japan (48)
Maryland (65)
Massachusetts (172)
Minnesota (23)
New Jersey (125)
New York (102)
North Carolina (50)
Northern California (109)
Pennsylvania (34)
South America (105)
Southern California (100)
Texas (16)
Utah (7)
Virginia (13)
69,227 Results for "biosight ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, announced the closing of its merger with Biosight, Ltd., pursuant to which Ayala acquired Biosight.
October 19, 2023
·
6 min read
Deals
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
Ayala Pharmaceuticals, Inc. and Biosight Ltd. today announced they have entered into a definitive merger agreement pursuant to which Ayala will combine with Biosight in an all-stock transaction.
July 27, 2023
·
11 min read
Press Releases
BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB
January 8, 2025
·
1 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Drug Development
Biosight Launches a Phase 1/2 Clinical Trial of Aspacytarabine in Combination with Venetoclax for First-Line AML Induction Therapy, Followed by Aspacytarabine Consolidation
Biosight Ltd today announced enrollment of a first patient to a phase 1/2 clinical trial designed to evaluate the safety and efficacy of its lead asset aspacytarabine (BST-236) in combination with the BCL2 inhibitor venetoclax for induction therapy of newly-diagnosed Acute Myeloid Leukemia (AML), followed by aspacytarabine single-agent consolidation therapy.
November 22, 2022
·
3 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Biosight Granted Orphan Drug Designation from the FDA for Aspacytarabine for the Treatment of Myelodysplastic Syndromes
Biosight Ltd., announced today that the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to aspacytarabine (BST-236), an investigational novel antimetabolite, for the treatment of myelodysplastic syndromes, in addition to the Orphan Drug Designation granted in 2019 for aspacytarabine for the treatment of acute myeloid leukemia (AML).
August 1, 2022
·
3 min read
1 of 6,923
Next
